uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Early hearing protection by brain-derived neurotrophic factor
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Otolaryngology and Head and Neck Surgery.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Otolaryngology and Head and Neck Surgery.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Otolaryngology and Head and Neck Surgery.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Otolaryngology and Head and Neck Surgery.
Show others and affiliations
2013 (English)In: Acta Oto-Laryngologica, ISSN 0001-6489, E-ISSN 1651-2251, Vol. 133, no 1, 12-21 p.Article in journal (Refereed) Published
Abstract [en]

Conclusion: Brain-derived neurotrophic factor (BDNF) protects the inner ear from PaExoA (exotoxin A from Pseudomonas aeruginosa)-induced sensory neural hearing loss when administered 12 h after exotoxin, but not after 72 h. Objective: BDNF is a peptide in the neurotrophin family with protective effects against noise-induced hair cell loss and toxic inner ear damage following exposure to cisplatin. The exotoxin A (PaExoA) from P. aeruginosa, the most common microorganism in chronic suppurative otitis media, induces sensorineural hearing loss in rats. Previous study showed that, when given simultaneously with the exotoxin, BDNF protected the inner ear from damage. The aim of this study was to determine if BDNF has a protective effect when given 12-72 h after PaExoA. Materials and Methods : Five groups of Sprague-Dawley rats were used. The three control groups (n = 16) were as follows. Group 1 (n = 8) received 15 mu g/20 mu l PaExoA; group 2 (n = 5) received 20 mu g/20 mu l PaExoA; and group 3 (n = 3) received 25 mu g/20 mu l PaExoA injected into the round window niche. There were two treatment groups (n = 12): group A (n = 6) received 15 mu g/20 mu l PaExoA and 4 mu g/20 mu l BDNF 12 h later; group B (n = 6) received 15 mu g/20 mu l PaExoA and 4 mu g/20 mu l BDNF 72 h later. Brainstem response audiometry (ABR) was performed on day 0 (control), and repeated on days 7, 14, 21, 28, and 35 to analyze the thresholds shifts. Results: Exposure to 15 mu g/20 mu l PaExoA caused persistent and significant ABR impairment in controls when measured after 35 days. A single dose of BDNF given 12 h after PaExoA reduced hearing loss significantly, but when BDNF was given 72 h after PaExoA no protective effect was evident.

Place, publisher, year, edition, pages
2013. Vol. 133, no 1, 12-21 p.
Keyword [en]
Brain-derived neurotrophic faktor, Pseudomonas aeruginosa, ABR, cochlea, hearing loss, rat
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-192430DOI: 10.3109/00016489.2012.712217ISI: 000312525800002OAI: oai:DiVA.org:uu-192430DiVA: diva2:600367
Available from: 2013-01-24 Created: 2013-01-21 Last updated: 2017-12-06Bibliographically approved
In thesis
1. Time-related Aspects of Otoprotection: Experimental Studies in Rat
Open this publication in new window or tab >>Time-related Aspects of Otoprotection: Experimental Studies in Rat
2013 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Intratympanic injection of various otoprotectants through the round window membrane (RWM) might become available in the near future as an alternative to the currently available medical and surgical methods used to treat several inner ear diseases. The most common outcome of such diseases is sensorineural hearing loss (SNHL).

Two examples of  these otoprotectants are Edaravone and Brain-Derived Neurotrophic Factor (BDNF), both of which have already proved effective against  noise-induced hair cell loss, barotrauma  and ototoxicity caused by cisplatin. In four different studies we used two electrophysiological methods, auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE), to study the effects of tobramycin and Pseudomonas aeruginosa exotoxin A (PaExoA) on the inner ears of 129 male Sprague-Dawley rats.

In two investigations, not only the otoprotective effects of Edaravone on tobramycin-induced ABR threshold shifts and PaExoA-induced DPOAE  threshold changes, were studied but even different application times, in order to establish in which interval it was still possible to achieve effective otoprotection.We found that Edaravone gave otoprotection from tobramycin when injected simultaneously or within 7 days, but it had only a limited effect on the changes in DPOAE thresholds caused by PaExoA when injected 1, 2, or 4 hours after the exotoxin.

The effect of BDNF on PaExoA-induced ABR threshold shifts was investigated in two studies, where different doses of intratympanically injected PaExoA were used and where BDNF was applied simultaneously, 12 or 72 hours efter exotoxin instillation. We found that BDNF had an otoprotective effect on SNHL induced by different doses PaExoA when injected simultaneously or with no more than 12 hours delay.

 

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2013. 49 p.
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 901
Keyword
sensorineural hearing loss, Edaravone, brain-derived neurotrophic factor, auditory brainstem response, Sprague-Dawley rat, distortion product otoacoustic emission, Pseudomonas aeruginosa exotoxin A.
National Category
Medical and Health Sciences
Research subject
Oto-Rhino-Laryngology
Identifiers
urn:nbn:se:uu:diva-198450 (URN)978-91-554-8661-7 (ISBN)
Public defence
2013-06-13, Skoogsalen, Akademiska sjukhuset (ingång 78-79), Uppsala, 09:15 (Swedish)
Opponent
Supervisors
Available from: 2013-05-22 Created: 2013-04-15 Last updated: 2013-08-30

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Lidian, AdnanStenkvist-Asplund, MonikaLinder, BirgittaAnniko, MattiNordang, Leif

Search in DiVA

By author/editor
Lidian, AdnanStenkvist-Asplund, MonikaLinder, BirgittaAnniko, MattiNordang, Leif
By organisation
Otolaryngology and Head and Neck Surgery
In the same journal
Acta Oto-Laryngologica
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 558 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf